Medicine
Tice BCG 50 mg/50 mL powder for injectable suspension
Tice BCG 50 mg/50 mL powder for injectable suspension is a prescription medicine containing Bacillus calmette-guerin substrain tice live antigen for intravesical use, marketed by Merck Sharp & Dohme, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
The intact vials of TICE ® BCG should be stored refrigerated, at 2–8°C…
Key facts
- Active ingredient (INN)
- Bacillus calmette-guerin substrain tice live antigen
- Brand
- Tice BCG
- Strength
- 50 mg/50 mL
- Dosage form
- Powder for injectable suspension
- Route
- Intravesical
- Packs
- 1 vial
- Marketing authorisation holder
- Merck Sharp & Dohme
- Manufacturer
- Merck Sharp & Dohme
- Origin register
- US FDA, United States
- Storage
- The intact vials of TICE ® BCG should be stored refrigerated, at 2–8°C (36–46°F). This agent contains live bacteria and should be protected from direct sunlight.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J07AN01 Bacillus calmette-guerin substrain tice live antigen
- HS code (indicative)
- 3002.41Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 August 1990
- Identifiers
- RxCUI 213744, 1653484DailyMed set ID c9b74876-e665-442b-87ad-b7333bc9a67aNDC 0052-0602Application BLA102821
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 50 mL in 1 vial | 0052-0602-02 | Merck Sharp & Dohme | 24 August 1990 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Bacillus calmette-guerin substrain tice live antigen is a live attenuated bacillus calmette-guerin immunotherapy. It is available as powder for injectable suspension for intravesical use. MedsAcross supplies Bacillus calmette-guerin substrain tice live antigen for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Bacillus calmette-guerin substrain tice live antigenFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TICE BCG prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
Need Tice BCG 50 mg/50 mL powder for injectable suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.